Mouse models are frequently used to study mechanisms of human diseases. Recently, we observed a spontaneous bimodal variation in liver weight in C57BL/6JOlaHsd mice fed a semisynthetic diet. We now characterized the spontaneous variation in liver weight and its relationship with parameters of hepatic lipid and bile acid (BA) metabolism. In male C57BL/6JOlaHsd mice fed AIN-93G from birth to postnatal day (PN)70, we measured plasma BA, lipids, Very low-density lipoprotein (VLDL)-triglyceride (TG) secretion, and hepatic mRNA expression patterns. Mice were sacrificed at PN21, PN42, PN63 and PN70. Liver weight distribution was bimodal at PN70. Mice could be subdivided into two nonoverlapping groups based on liver weight: 0.6 SD 0.1 g (approximat...
Nonalcoholic fatty liver disease (NAFLD) in non-obese patients remains a clinical condition with unc...
Background Emerging data support a role for lipids in non-alcoholic steatohepatitis (NASH) and hepat...
The major risk factors for non-alcoholic fatty liver disease (NAFLD) are obesity, insulin resistance...
Mouse models are frequently used to study mechanisms of human diseases. Recently, we observed a spon...
Objectives and study: The mouse is a frequently used species in experimental models for human diseas...
Background Non-alcoholic steatohepatitis (NASH) is a common disease and feeding mice a methionine-ch...
<div><p>Background and aims</p><p>Non-alcoholic steatohepatitis (NASH), the potentially progressive ...
Although non-alcoholic and alcoholic fatty liver disease have been intensively studied, concerning p...
<p>(A) Mouse livers were weighed <i>ex vivo</i> after each feeding period. Only the NPD/HFHC-fed mic...
International audienceBACKGROUND AND AIMS: Non-alcoholic steatohepatitis (NASH), the potentially pro...
Nonalcoholic steatohepatitis (NASH) and nonalcoholic fatty liver disease (NAFLD) are increasing prob...
Background & AimsThe lack of a preclinical model of progressive non-alcoholic steatohepatitis (NASH)...
Background & aimsThe accumulation of neutral lipids within hepatocytes underlies non-alcoholic f...
Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH), which are usuall...
<p>WT or miR-155<sup>−/−</sup> mice were fed either normal chow or HFD and livers examined at 24 wee...
Nonalcoholic fatty liver disease (NAFLD) in non-obese patients remains a clinical condition with unc...
Background Emerging data support a role for lipids in non-alcoholic steatohepatitis (NASH) and hepat...
The major risk factors for non-alcoholic fatty liver disease (NAFLD) are obesity, insulin resistance...
Mouse models are frequently used to study mechanisms of human diseases. Recently, we observed a spon...
Objectives and study: The mouse is a frequently used species in experimental models for human diseas...
Background Non-alcoholic steatohepatitis (NASH) is a common disease and feeding mice a methionine-ch...
<div><p>Background and aims</p><p>Non-alcoholic steatohepatitis (NASH), the potentially progressive ...
Although non-alcoholic and alcoholic fatty liver disease have been intensively studied, concerning p...
<p>(A) Mouse livers were weighed <i>ex vivo</i> after each feeding period. Only the NPD/HFHC-fed mic...
International audienceBACKGROUND AND AIMS: Non-alcoholic steatohepatitis (NASH), the potentially pro...
Nonalcoholic steatohepatitis (NASH) and nonalcoholic fatty liver disease (NAFLD) are increasing prob...
Background & AimsThe lack of a preclinical model of progressive non-alcoholic steatohepatitis (NASH)...
Background & aimsThe accumulation of neutral lipids within hepatocytes underlies non-alcoholic f...
Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH), which are usuall...
<p>WT or miR-155<sup>−/−</sup> mice were fed either normal chow or HFD and livers examined at 24 wee...
Nonalcoholic fatty liver disease (NAFLD) in non-obese patients remains a clinical condition with unc...
Background Emerging data support a role for lipids in non-alcoholic steatohepatitis (NASH) and hepat...
The major risk factors for non-alcoholic fatty liver disease (NAFLD) are obesity, insulin resistance...